STOCK TITAN
  1. Home
  2. Financials
  3. LABT

Lakewood-Amedex Financials

LABT
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Lakewood-Amedex (LABT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score pending refresh

We are recalculating Lakewood-Amedex's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
N/A
EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$236K

Lakewood-Amedex held $236K in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share
N/A
Shares Outstanding
7M

Lakewood-Amedex had 7M shares outstanding in fiscal year 2026.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

LABT Income Statement

Metric Q1'26 Q4'25 Q1'25
Revenue N/A N/A N/A
Cost of Revenue $507K N/A N/A
Gross Profit N/A N/A N/A
R&D Expenses $182K N/A $170K
SG&A Expenses $703K N/A $372K
Operating Income -$887K N/A -$543K
Interest Expense $38K N/A $1K
Income Tax N/A N/A N/A
Net Income -$923K N/A -$540K
EPS (Diluted) $-0.20 N/A $-0.15

LABT Balance Sheet

Metric Q1'26 Q4'25 Q1'25
Total Assets $196K-59.2% $482K N/A
Current Assets $51K-83.4% $305K N/A
Cash & Equivalents $12K-95.0% $236K-50.4% $477K
Inventory N/A N/A N/A
Accounts Receivable N/A N/A N/A
Goodwill N/A N/A N/A
Total Liabilities $3.0M+24.2% $2.4M N/A
Current Liabilities $3.0M+25.9% $2.4M N/A
Long-Term Debt N/A N/A N/A
Total Equity -$2.8M-44.6% -$2.0M-2477.0% -$76K
Retained Earnings -$54.3M-1.7% -$53.4M N/A

LABT Financial Ratios

Metric Q1'26 Q4'25 Q1'25
Gross Margin N/A N/A N/A
Operating Margin N/A N/A N/A
Net Margin N/A N/A N/A
Return on Equity N/A N/A N/A
Return on Assets -470.2% N/A N/A
Current Ratio 0.02-0.1 0.13 N/A
Debt-to-Equity N/A N/A N/A
FCF Margin N/A N/A N/A

Note: Shareholder equity is negative (-$2.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.13), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Lakewood-Amedex (LABT) had $482K in total assets as of fiscal year 2026, including both current and long-term assets.

Lakewood-Amedex (LABT) had 7M shares outstanding as of fiscal year 2026.

Lakewood-Amedex (LABT) had a current ratio of 0.13 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

Lakewood-Amedex (LABT) has negative shareholder equity of -$2.0M as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top